ADSCC to hire 1,000 citizens in five years
ABU DHABI: In line with the vision of the prudent leadership regarding “Projects of the 50,” the Abu Dhabi Stem Cell Centre (ADSCC) revealed its plan to hire 1,000 citizens during the next five years in the administrative and medical areas, and the training of Emirati medical cadres.
ADSCC announced its intention to expand the scope of its programme to atract and develop Emirati talents, with the view of providing more job opportunities for the citizens nationwide in its various sectors.
As part of the ADSCC’S contribution to the “Nafis” programme, which was launched by the UAE Government, it announced its commitment to implementing a series of initiatives that focuses on developing the national cadres to motivate them to work in the private sector.
The partnership with the “Nafis” programme embodies a crucial step for the private sector to enhance its contribution to supporting the “Projects of the 50” across the country. All citizens wishing to join the ADSCC can send their CVS to the initiative’s e-mail: (hr@adscc.ae ).
The ADSCC will create and develop 1,000 new job opportunities for Emirati citizens wishing to build their career in the private sector over the next five years.
Abu Dhabi Stem Cells Center is a specialist healthcare centre focused on cell therapy and regenerative medicine techniques, as well as delivering cuting-edge research on stem cells in the region.
The Centre was founded in March 2019 to meet growing domestic and regional demand for highly specialised medical services and treatments. Equipped with the latest technologies, medical devices that are unique to the region, and a team of internationally recognised doctors working hand in hand with researchers, ADSCC is the first of its kind in the UAE.
Specialties include immunology, hematology, clinicalstemcelltherapy,molecularbiology,immunotherapy, orthopedics, and urology – amongst others.
The Centre focuses primarily on harvesting, processing, characterising and storing cell products for clinical application in both regenerative medicine and hematopoietic transplantation. It aims to streamline and develop new processes related to stem cell therapy and research, in order to both serve our team of doctors’ clinical needs and become a referral center for the region.